http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008150430-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26 |
| filingDate | 2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2008150430-A |
| titleOfInvention | PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF PIPERIDINOALKANOL AND ANTI-FLOW AGENT |
| abstract | 1. A pharmaceutical composition comprising! a) a mixture containing the first therapeutic agent, and! b) a lot of particles inside the mixture, while the particles include! (i) the inside containing the second therapeutic agent, and! (ii) the outer part containing a substance for regulating the release of the second therapeutic agent. ! 2. The pharmaceutical composition according to claim 1, in which the inner part contains an inner core and an intermediate layer located on top of the inner core, while the inner core contains a pharmaceutically inactive substance, and the intermediate layer contains a second therapeutic agent. ! 3. The pharmaceutical composition according to claim 2, in which at least 85% of the inner cores has a size in the range from 100 to 1000 microns. ! 4. The pharmaceutical composition according to claim 3, in which at least 85% of the inner cores has a size in the range from 100 to 850 microns. ! 5. The pharmaceutical composition according to claim 4, in which at least 85% of the inner cores has a size in the range from 100 to 710 microns. ! 6. The pharmaceutical composition according to claim 5, in which at least 85% of the inner cores has a size in the range from 100 to 500 microns. ! 7. The pharmaceutical composition according to claim 6, in which at least 85% of the inner cores has a size in the range from 100 to 425 microns. ! 8. The pharmaceutical composition according to claim 7, in which at least 85% of the inner cores has a size in the range from 100 to 355 microns. ! 9. The pharmaceutical composition of claim 8, in which at least 85% of the inner cores has a size in the range from 200 to 355 microns. ! 10. The pharmaceutical composition according to any one of claims 2 to 9, in which the inner cores contain granules of microcrystalline cellulose or sugar g |
| priorityDate | 2006-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.